Patient Engagement in R&D: Still a Challenge for Pharma Companies
DUBLIN–(BUSINESS WIRE)–The “Patient Engagement in R&D: Still a Challenge” report has been added to ResearchAndMarkets.com’s offering. The pharmaceutical industry has…
Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Patient Engagement in R&D: Still a Challenge” report has been added to ResearchAndMarkets.com’s offering. The pharmaceutical industry has…
DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. The biopharmaceuticals market is driven…
CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS) announced today that multiple abstracts featuring the INTERCEPT Blood System pathogen reduction technology, including four…
-GENFIT partnership expands Terns’ portfolio, adding a Phase 3 product with a complementary mechanism of action well-suited to combinations with…
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced that Eric…
U.S. Patent Office and European Patent Office issue allowances of patent applications relating to iduronate-2-sulfatase (“IDS”) polypeptide/xB3 conjugates European Patent…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
DUBLIN–(BUSINESS WIRE)–The “Cryptosporidiosis Global Clinical Trials Review, H1, 2019” clinical trials has been added to ResearchAndMarkets.com’s offering. Cryptosporidiosis Global Clinical…